BORDEAUX, France, July 9, 2024
/PRNewswire/ -- TreeFrog Therapeutics, the French biotech company
advancing a pipeline of regenerative medicine cell therapies based
on a disruptive proprietary technology platform will present at
several events at the global stem cell event in Hamburg, including a poster session with data
from their lead program in Parkinson's Disease and an innovation
showcase with a deep dive on their transformational technology,
C-Stem™.
Regenerative medicine holds immense potential in addressing some
of the largest unmet needs in diseases of the major organs such as
the central nervous system, the liver, pancreas and heart. However,
despite major advances in the last 70 years, there are still
bottlenecks holding up innovation, particularly, the ability to
produce the required amount of high-quality cells, efficiently.
TreeFrog's lead program in Parkinson's disease has proven
efficacy in pre-clinical models using a unique approach of grafting
3D format microtissues containing dopaminergic progenitors and
mature dopaminergic neurons, as opposed to single-cell suspensions.
The poster, presented by Maxime Feyeux, Chief Scientific
Officer and Co-founder of TreeFrog will highlight the
therapeutic potential of the 3D approach, and delve deeper into the
characterization of the product through complementary methods
including qPCR, RNAseq, flow cytometry and microscopy.
The pipeline of TreeFrog is based on their
C-Stem™ technology, the culmination of over 20 years of
research bringing the best in biophysics and stem cell biology
together. This breakthrough technology addresses the challenges of
scale and quality, and the closed system enables both the
amplification and differentiation of cells. Maxime will be
joined by two senior scientists – Joffrey Mianne, Head of iPSC
Research and Clement Rieu,
Head of Technologies R&D - during an innovation showcase
about C-Stem™.
Presentations details:
Poster Presentation: #190
Clinical Applications (CA) Session
Wednesday, July 10, 2024 @ 6:45 PM – 7:45
PM
Room: Poster & Exhibit hall
Innovation Showcase
Thursday July 11th, 2024 @
6:00PM – 6:30PM
Room: Hall 3, entrance level
About TreeFrog Therapeutics
TreeFrog
Therapeutics is a biotech company set to unlock access to
cell therapies for millions of patients bringing together
biophysicists, cell biologists and bioproduction
engineers to address the challenges of producing and
differentiating cells of quality at unprecedented scale,
cost-effectively. To realize their mission of Cell
Therapy for all, TreeFrog has their own
therapeutic programs and partnerships with leading biotech and
industry players in other areas.
www.treefrog.fr
Contact:
Rachel Mooney
Chief Communications Officer
TreeFrog Therapeutics
Rachel.mooney@treefrog.fr
Logo -
https://mma.prnewswire.com/media/2272329/treefrog_Logo.jpg
View original
content:https://www.prnewswire.com/news-releases/treefrog-therapeutics-participates-in-an-innovation-showcase--poster-session-at-the-international-society-for-stem-cell-research-isscr-annual-meeting-302191058.html
SOURCE TreeFrog Therapeutics